The Predictive Potential of Elevated Serum Inflammatory Markers in Determining the Need for Intubation in CoVID-19 Patients
, , , , , , , , , e
13 nov 2021
INFORMAZIONI SU QUESTO ARTICOLO
Categoria dell'articolo: Research article
Pubblicato online: 13 nov 2021
Pagine: 14 - 22
Ricevuto: 15 dic 2020
Accettato: 31 ago 2021
DOI: https://doi.org/10.2478/jccm-2021-0035
Parole chiave
© 2022 Samuel Windham, Kellen Hirsch, Ryan Peterson, David Douin, Lakshmi Chauhan, Lauren Heery, Connor Fling, Nemanja Vukovic, Fernando Holguin, Shanta Zimmer, Kristine Erlandson, published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Fig.1

Fig. 2

Baseline Characteristics of Hospitalised CoVID-19 Patients
Overall (N=158) | |
---|---|
Clinical Characteristics | |
Age | 56.2 (16.8) |
BMI | 31.3 (8.0) |
Male | 81 (51.3%) |
Active Tobacco Use | 9 (5.8%) |
White, non-Hispanic | 30 (19.5%) |
Black | 53 (34.4%) |
Hispanic | 45 (29.2%) |
Asian | 11 (7.1%) |
Other | 15 (9.7%) |
Diabetes | 47 (30.3%) |
Hypertension | 87 (56.1%) |
COPD | 11 (7.1%) |
Creatinine >2 mg/dL on Admission | 4 (2.5%) |
Cirrhosis | 3 (1.9%) |
Coronary Artery Disease | 18 (11.6%) |
Active Cancer | 11 (7.1%) |
Immunosuppressed | 10 (6.5%) |
Subjective Fever | 111 (74.0%) |
Cough | 126 (82.4) |
Diarrhoea | 40 (26.8%) |
Nausea/Vomiting | 42 (28.2%) |
Myalgia | 34 (22.8%) |
Dyspnoea | 116 (75.3%) |
Duration of Symptoms | 6.7 (4.6) |
Unilateral Infiltrate | 28 (17.8%) |
Bilateral Infiltrate | 102 (65%) |
Other Findings | 28 (17.8%) |
Intubation Indicated | 64 (40.5%) |
Vasopressors Indicated | 42 (26.6%) |
Prone Positioned | 24 (15.2%) |
Deceased | 4 (2.5%) |
Discharge | 55 (36.9%) |
Characteristics of Intubated CoVID-19 Patients
Overall (N=64) | |
---|---|
Oxygen Requirement on Admission in Litres of Oxygen | 5.6 (13.2) |
Highest Oxygen Requirement Stable >1 Hour within 24 Hours of Admission in Litres of Oxygen | 5.0 (4.1) |
Use of Non-Invasive Ventilation Before Intubation | 1 (1.6%) |
Oxygen Requirement within one hour of Intubation in Litres of Oxygen | 12.9 (12.7) |
SOFA on Intubation | 4.5 (2.1) |
Days Intubated | 11.926 (8.519) |
P:F Ratio at 8h | 146.3 (84.1) |
P:F Ratio at 16h | 194.9 (69.1) |
P:F Ratio at 24h | 204.0 (63.4) |
P:F Ratio at 32h | 216.8 (65.5) |
P:F Ratio at 40h | 216.2 (65.9) |
P:F Ratio at 48h | 204.7 (75.3) |
P:F Ratio at 56h | 212.5 (73.9) |
P:F Ratio at 64h | 217.0 (71.2) |
P:F Ratio at 72h | 219.9 (81.4) |
P:FP Ratio at 8h | 12.3 (7.4) |
P:FP Ratio at 16h | 17.3 (9.8) |
P:FP Ratio at 24h | 17.5 (8.0) |
P:FP Ratio at 32h | 19.1 (8.8) |
P:FP Ratio at 40h | 20.1 (10.8) |
P:FP Ratio at 48h | 18.2 (13.7) |
P:FP Ratio at 56h | 19.1 (9.5) |
P:FP Ratio at 64h | 20.6 (12.8) |
P:FP Ratio at 72h | 21.2 (13.0) |
Characteristics of Hospitalised CoVID-19 Patients Stratified by Intubation Status
Not Intubated (N=94) | Intubated (N=64) | N-Missing (Not intubated/ Intubated) | p-value | |
---|---|---|---|---|
Age | 55.36 (17.33) | 57.32 (15.90) | 0/1 | 0.415 |
BMI | 30.85 (7.84) | 32.01 (8.2) | 5/0 | 0.436 |
Male | 45 (47.9%) | 36 (56.2%) | NA | 0.333 |
Active Tobacco Use | 4 (4.3%) | 5 (8.1%) | NA | 0.485 |
Non-White Race and/or Hispanic | 71 (76.3%) | 53 (86.9%) | NA | 0.145 |
Ethnicity | ||||
Diabetes | 21 (22.3%) | 26 (42.6%) | NA | 0.012 |
Hypertension | 52 (55.3%) | 35 (57.4%) | NA | 0.869 |
COPD | 6 (6.4%) | 5 (8.2%) | NA | 0.753 |
Creatinine >2 mg/dL on Admission | 1 (1.1%) | 3 (4.8%) | NA | 0.303 |
Cirrhosis | 1 (1.1%) | 2 (3.3%) | NA | 0.562 |
Coronary Artery Disease | 12 (12.8%) | 6 (9.8%) | NA | 0.620 |
Active Cancer | 6 (6.4%) | 5 (8.2%) | NA | 0.753 |
Immunosuppressed | 8 (8.6%) | 2 (3.3%) | NA | 0.317 |
Subjective Fever | 72 (77.4%) | 39 (68.4%) | NA | 0.253 |
Cough | 75 (79.8%) | 51 (86.4%) | NA | 0.385 |
Diarrhoea | 30 (32.3%) | 10 (17.9%) | NA | 0.059 |
Nausea/Vomiting | 33 (35.5%) | 9 (16.1%) | NA | 0.014 |
Myalgia | 20 (21.5%) | 14 (25%) | NA | 0.688 |
Dyspnoea | 74 (78.7%) | 42 (70%) | NA | 0.253 |
Duration of Symptoms | 6.7 (4.53) | 6.57 (4.81) | 1/6 | 0.796 |
Clear | 12 (13.8%) | 4 (6.3%) | NA | 0.192 |
Unilateral Infiltrate | 21 (22.3%) | 7 (11.1%) | NA | 0.090 |
Bilateral Infiltrate | 51 (54.3%) | 51 (81%) | NA | <0.001 |
Pleural Effusion | 0 (0%) | 2 (3.2%) | NA | 0.159 |
Other Finding | 6 (6.4%) | 3 (4.8%) | NA | 0.741 |
CRP mg/L | 70.34 (60.5) | 142.50 (83.36) | 2/6 | <0.001 |
LDH U/L | 311.53 (102.3) | 415.37 (160.22) | 5/13 | <0.001 |
D-dimer FEU | 1199.23 (1692.86) | 4475.20 (14140.16) | 15/14 | 0.033 |
Ferritin ng/mL | 428.47 (426.81) | 790.62 (1236.12) | 7/17 | 0.079 |
Neutrophils x10^9/L | 4.55 (2.11) | 7.20 (3.68) | 59/24 | <0.001 |
Lymphocytes x10^9/L | 3.60 (14.03) | 1.08 (0.63) | 59/24 | 0.067 |
NLR | 4.20 (2.41) | 8.33 (6.51) | 59/24 | <0.001 |
Deceased | 2 (2.1%) | 2 (3.1%) | NA | 1.00 |
Discharged | 53 (57.6%) | 2 (3.5%) | NA | <0.001 |
Covariate Effects on Odds of Intubation
Unadjusted | Adjusted * | |||||
---|---|---|---|---|---|---|
Term | OR | 95% CI | p-value | OR | 95% CI | p-value |
1 SD change in CRP (78.0 mg/L) | 3.05 | (1.9, 4.8) | <0.001 | 2.81 | (1.8, 4.5) | <0.001 |
1 SD change in LDH (135.6 U/L) | 2.31 | (1.5, 3.6) | <0.001 | 2.10 | (1.3, 3.3) | 0.002 |
1 SD change in Log D-Dimer (0.94 log FEU) | 1.47 | (1, 2.2) | 0.048 | 1.33 | (0.8, 2.1) | 0.22 |
1 SD change in NLR (5.4) | 1.94 | (1.1, 3.5) | 0.031 | 2.21 | (1.1, 4.5) | 0.033 |
1 SD change in Log Ferritin (1.12 log ng/mL) | 1.45 | (1, 2.1) | 0.055 | 1.29 | (0.9, 1.9) | 0.23 |
1 SD change in BMI (8.0 kg/m2) | 1.15 | (0.8, 1.6) | 0.39 | 1.07 | (0.7, 1.6) | 0.71 |
1 SD change in age (16.8 years) | 1.13 | (0.8, 1.6) | 0.45 | 1.15 | (0.8, 1.7) | 0.48 |
Symptom Duration | 0.99 | (0.9, 1.1) | 0.86 | 0.99 | (0.9, 1.1) | 0.72 |
DM | 2.52 | (1.3, 5.1) | 0.010 | 1.98 | (0.9, 4.3) | 0.081 |
Ethnicity/Race is Non-White | 2.08 | (0.9, 5) | 0.10 | 1.96 | (0.8, 5.1) | 0.17 |
Bilateral Infiltrate on X-Ray | 3.6 | (1.7, 7.6) | 0.001 | 3.39 | (1.5, 7.6) | 0.003 |